Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|July 9, 2011
Beyond ipilimumab: new approaches target the immunological synapseKen Garber
Nature Biotechnology|November 10, 2011
Hepatitis C: move over interferonKen Garber
Nature Biotechnology|March 9, 2012
Mission therapeuticsKen Garber
Nature Biotechnology|April 12, 2012
Biologics inch toward cholesterol-lowering marketKen Garber
Nature Reviews. Drug Discovery|August 2, 2014
MET inhibitors start on road to recoveryKen Garber
Nature Reviews. Drug Discovery|September 12, 2020
First microbiome-based drug clears phase III, in clinical trial turnaroundKen Garber
Nature Biotechnology|June 10, 2021
Synthekine: beyond cytokinesKen Garber
Science (New York, N.Y.)|July 6, 2019
Epigenetics comes to RNAKen Garber
Nature Biotechnology|August 4, 2025
Editor's Pick: Seaport TherapeuticsKen Garber
Nature Biotechnology|May 7, 2016
No longer going to wasteKen Garber
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|July 9, 2011
Beyond ipilimumab: new approaches target the immunological synapseKen Garber
Nature Biotechnology|November 10, 2011
Hepatitis C: move over interferonKen Garber
Nature Biotechnology|March 9, 2012
Mission therapeuticsKen Garber
Nature Biotechnology|April 12, 2012
Biologics inch toward cholesterol-lowering marketKen Garber
Nature Reviews. Drug Discovery|August 2, 2014
MET inhibitors start on road to recoveryKen Garber
Nature Reviews. Drug Discovery|September 12, 2020
First microbiome-based drug clears phase III, in clinical trial turnaroundKen Garber
Nature Biotechnology|June 10, 2021
Synthekine: beyond cytokinesKen Garber
Science (New York, N.Y.)|July 6, 2019
Epigenetics comes to RNAKen Garber
Nature Biotechnology|August 4, 2025
Editor's Pick: Seaport TherapeuticsKen Garber
Nature Biotechnology|May 7, 2016
No longer going to wasteKen Garber
Pageof 20